Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0106403001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 00029246 | BAUSCH HEALTH, CANADA INC. | DELATESTRYL | Human | Yes | Schedule G (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
Cancelled Post Market | 02027054 | GERMIPHENE CORPORATION | MALOGEX LA200 LIQ 200MG/ML | Human | No | Schedule G (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
Cancelled Post Market | 00739944 | PHARMASCIENCE INC | PMS-TESTOSTERONE ENANTHATE INJ 200MG/ML USP | Human | No | Schedule G (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
Cancelled Post Market | 00716936 | TARO PHARMACEUTICALS INC | TESTOSTERONE ENANTHATE INJ 200MG/ML | Human | No | Schedule G (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
Marketed | 02536315 | HIKMA CANADA LIMITED | TESTOSTERONE ENANTHATE INJECTION, USP | Human | Yes | Schedule G (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
Application information
Related information
Contact us
Version 4.0.3